Related Experiment Videos
Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene
1Howard Hughes Medical Institute, University of Utah, Salt Lake City, Utah 84112, USA.
Abstract:
Human colon carcinoma cell line HCT116 harbors an oncogenic Ki-ras gene. Introduction of an exogenous full-length NF1 gene or its GTPase-activating protein (GAP)-related domain suppressed the tumor-forming ability of this cell line in nude mice. A GAP-related domain peptide carrying a K1423E mutation, which shows greatly diminished GAP activity but a normal binding affinity for p2lras-GTP, was also tested. This construct was able to suppress tumor formation by the HCT116 cell line, thus ruling out the possibility that the observed tumor suppression is due to the GAP activity of NF1. Reduced Raf-1 kinase activity in cells which expressed these NF1 constructs suggested that neurofibromin may interfere with the interaction between Ras and Raf. Introduction of a mutationally activated Raf-1 kinase domain reversed tumor suppression by neurofibromin, implicating Raf-1 as the primary downstream transducer of the oncogenic Ras signal. An increase in apoptotic cell death, which could be delayed by activated Raf-1 kinase, was also seen in cells carrying the exogenous NF1 gene.
Insights
Neurofibromin (NF1) suppresses colon cancer growth by inhibiting Raf-1 kinase, not through its GTPase-activating protein (GAP) activity. This highlights NF1
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Human colon carcinoma (HCT116) cells possess an oncogenic Ki-ras gene.
- Neurofibromin (NF1) is a tumor suppressor gene.
- Ras signaling pathways are crucial in cancer development.
Purpose of the Study:
- To investigate the mechanism by which NF1 suppresses tumor formation in HCT116 cells.
- To determine if NF1's GTPase-activating protein (GAP) activity is responsible for tumor suppression.
- To identify the downstream effectors of NF1 in Ras-mediated oncogenesis.
Main Methods:
- Introduction of exogenous full-length NF1 gene and its GAP-related domain into HCT116 cells.
- Testing a mutated NF1 GAP-related domain peptide with diminished GAP activity but normal Ras-GTP binding.
- Assessing tumor formation in nude mice.
- Measuring Raf-1 kinase activity and Ras-Raf interaction.
- Evaluating apoptotic cell death.
Main Results:
- Both full-length NF1 and its GAP-related domain suppressed HCT116 tumor formation.
- A mutated NF1 construct lacking GAP activity also suppressed tumor formation, ruling out GAP activity as the sole mechanism.
- NF1 expression reduced Raf-1 kinase activity, suggesting interference with Ras-Raf interaction.
- A mutationally activated Raf-1 kinase domain reversed NF1-mediated tumor suppression.
- NF1 expression increased apoptotic cell death, which was delayed by activated Raf-1.
Conclusions:
- NF1 suppresses colon cancer tumor formation independently of its GAP activity.
- NF1 inhibits oncogenic Ras signaling primarily by interfering with Raf-1 kinase.
- Raf-1 is a key downstream mediator of oncogenic Ras in this model.
- NF1-induced apoptosis is linked to Raf-1 inhibition.